FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer

NCT06877949 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

420

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Response Monitoring

Interventions

DIAGNOSTIC_TEST: FDG-PET/CT
DIAGNOSTIC_TEST: CE-CT

Sponsor

Odense University Hospital